Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Study on the Molecular Mechanism of High Altitude Heart Disease in Children. | Pharmgenomics Pers Med | 2022 | 35903087 | PubTator, text mining | PubMed |
| RUNX1T1 function in cell fate. | Stem Cell Res Ther | 2022 | 35902872 | PubTator, text mining | PubMed |
| Functions and Interactions of Mammalian KDM5 Demethylases. | Front Genet | 2022 | 35899196 | PubTator, text mining | PubMed |
| Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells. | Proteomes | 2022 | 35893764 | PubTator, text mining | PubMed |
| Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. | Clin Transl Sci | 2022 | 35892315 | PubTator, text mining | PubMed |
| Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. | Pharmaceuticals (Basel) | 2022 | 35890106 | PubTator, text mining | PubMed |
| Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. | Pharmaceuticals (Basel) | 2022 | 35890085 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment. | Cancers (Basel) | 2022 | 35884382 | PubTator, text mining | PubMed |
| The Hepatoprotective Effect of Leonurine Hydrochloride Against Alcoholic Liver Disease Based on Transcriptomic and Metabolomic Analysis. | Front Nutr | 2022 | 35873419 | PubTator, text mining | PubMed |
| Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/β-catenin signalling pathways. | Br J Dermatol | 2022 | 35862273 | PubTator, text mining | PubMed |
| Correction to: Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis. | J Am Heart Assoc | 2022 | 35862234 | PubTator, text mining | PubMed |
| Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis. | Eur J Endocrinol | 2022 | 35861986 | PubTator, text mining | PubMed |
| Uncovering Signals of Positive Selection in Peruvian Populations from Three Ecological Regions. | Mol Biol Evol | 2022 | 35860855 | PubTator, text mining | PubMed |
| A computational evaluation of FDA medicines' ability to inhibit hypoxia-inducible factor prolyl hydroxylase-2 (PHD-2) for acute respiratory distress syndrome. | Struct Chem | 2022 | 35855326 | PubTator, text mining | PubMed |
| Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis. | BMC Cancer | 2022 | 35854233 | PubTator, text mining | PubMed |
| Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease. | Alzheimers Dement | 2022 | 35852137 | PubTator, text mining | PubMed |
| PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia. | Acta Pharm Sin B | 2022 | 35847518 | PubTator, text mining | PubMed |
| Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. | EMBO J | 2022 | 35844135 | PubTator, text mining | PubMed |
| IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β0-Thalassemia/Hemoglobin E Erythroid Progenitor Cells. | Exp Hematol | 2022 | 35839944 | PubTator, text mining | PubMed |
| Therapeutic angiogenesis-based strategy for peripheral artery disease. | Theranostics | 2022 | 35836800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=40